98 related articles for article (PubMed ID: 16893070)
1. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
Rus H; Cudrici C; Niculescu F
Adv Exp Med Biol; 2006; 586():139-51. PubMed ID: 16893070
[No Abstract] [Full Text] [Related]
2. C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection.
Rus H; Cudrici C; Niculescu F
Ann Med; 2005; 37(2):97-104. PubMed ID: 16026117
[TBL] [Abstract][Full Text] [Related]
3. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
Rus H; Cudrici C; Niculescu F; Shin ML
J Neuroimmunol; 2006 Nov; 180(1-2):9-16. PubMed ID: 16905199
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.
Tegla CA; Cudrici C; Rus V; Ito T; Vlaicu S; Singh A; Rus H
J Neuroimmunol; 2009 Aug; 213(1-2):3-11. PubMed ID: 19577811
[TBL] [Abstract][Full Text] [Related]
5. Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis.
Niculescu T; Weerth S; Niculescu F; Cudrici C; Rus V; Raine CS; Shin ML; Rus H
J Immunol; 2004 May; 172(9):5702-6. PubMed ID: 15100315
[TBL] [Abstract][Full Text] [Related]
6. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory disease: assault on the guardian.
Ransohoff RM
Nature; 2007 Jul; 448(7152):421-2. PubMed ID: 17653181
[No Abstract] [Full Text] [Related]
8. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
[TBL] [Abstract][Full Text] [Related]
9. The membrane attack complex of complement causes severe demyelination associated with acute axonal injury.
Mead RJ; Singhrao SK; Neal JW; Lassmann H; Morgan BP
J Immunol; 2002 Jan; 168(1):458-65. PubMed ID: 11751993
[TBL] [Abstract][Full Text] [Related]
10. The complement system in central nervous system diseases.
Rus H; Cudrici C; David S; Niculescu F
Autoimmunity; 2006 Aug; 39(5):395-402. PubMed ID: 16923539
[TBL] [Abstract][Full Text] [Related]
11. Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system.
Zipp F; Krammer PH; Weller M
Immunol Today; 1999 Dec; 20(12):550-4. PubMed ID: 10562705
[No Abstract] [Full Text] [Related]
12. The role of the complement system in the pathogenesis of experimental autoimmune encephalomyelitis and multiple sclerosis.
Terényi N; Prechl J; Erdei A
Adv Exp Med Biol; 2006; 586():177-88. PubMed ID: 16893072
[No Abstract] [Full Text] [Related]
13. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement.
Cudrici C; Niculescu T; Niculescu F; Shin ML; Rus H
J Rehabil Res Dev; 2006; 43(1):123-32. PubMed ID: 16847778
[TBL] [Abstract][Full Text] [Related]
15. Medicine: Collateral damage repaired.
Steinman L
Nature; 2003 Apr; 422(6933):671-2. PubMed ID: 12700743
[No Abstract] [Full Text] [Related]
16. LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune encephalomyelitis mice.
Sun JJ; Ren QG; Xu L; Zhang ZJ
Sci Rep; 2015 Sep; 5():14235. PubMed ID: 26383267
[TBL] [Abstract][Full Text] [Related]
17. Oligodendrocyte apoptosis before immune attack in multiple sclerosis?
Pender MP
Ann Neurol; 2005 Jan; 57(1):158; author reply 158-9. PubMed ID: 15622546
[No Abstract] [Full Text] [Related]
18. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation.
Soane L; Rus H; Niculescu F; Shin ML
J Immunol; 1999 Dec; 163(11):6132-8. PubMed ID: 10570303
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of action of glatiramer acetate in multiple sclerosis and beyond.
Aharoni R
Autoimmun Rev; 2013 Mar; 12(5):543-53. PubMed ID: 23051633
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective agents: cannabinoids.
Sánchez AJ; García-Merino A
Clin Immunol; 2012 Jan; 142(1):57-67. PubMed ID: 21420365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
